Jessica L. Schneck

机构：Glaxosmithkline (Finland) · ORCID：0009-0007-2312-825X

发表论文 17 篇 · 总被引 71 次 · h-index 4

代表论文

• Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells (2024 · Cancer Discovery · 被引 55)
• Identification of an allosteric site on the E3 ligase adapter cereblon (2026 · Nature · 被引 8)
• Abstract ND10: An innovative and reversible WRN helicase inhibitor, GSK4418959 (IDE275), emerges as a promising clinical candidate for MSI-H cancers (2025 · Cancer Research · 被引 4)
• Abstract 5750: Discovery of GSK4418959 (IDE275): A novel, non-covalent, reversible Werner Helicase inhibitor and a new potential therapeutic for the treatment of MSI-H cancers (2025 · Cancer Research · 被引 4)
• Table S1 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells (2026)
• Table S3 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells (2026)